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ABSTRACT
The simultaneous presence of primary carcinomas in the same patient is uncommon and 
synchronous primary tumors involving the kidney and pancreas are extremely rare. There are 
a few reports in the English literature of synchronous primary malignancies of the kidney and 
pancreas. We present a 62-year-old man who had weight loss of 9 kg and epigastric pain. Findings 
showed a Furhman grade II renal papillary carcinoma confined to the kidney and a synchronous 
well differentiated pancreatic ductal adenocarcinoma. 
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INTRODUCTION                                                    
Renal cell carcinoma accounts for 
approximately 3% of adult malignancies1. 
Reports of synchronous or metachronous 
cancers of the kidney and pancreas are very 
rare and poorly documented2. We observed an 
unusual case of a 62-year-old man showing 
the contemporaneous presence of papillary 
carcinoma of the kidney and pancreatic ductal 
adenocarcinoma.
CASE REPORT                                      
A 62-year-old non-smoking male 
presented with a 4-month history of 
epigastric pain and episodes of nausea and 
vomiting associated with weight loss of 9 
kg. He had no hematuria or other urinary 
symptoms. He had no family history of renal 
or pancreatic diseases or familial genetic 
syndromes. On physical examination, no 
palpable mass or tenderness was revealed. 
Laboratory investigations showed a normal 
carcinoembryonic antigen (CEA) level and 
increased serum  carbohydrate antigen (CA) 
19-9 level (166 IU/ml). 
Abdominal ultrasound (US) revealed a 
solid mass (4 cm in diameter) in the body of the 
pancreas. Abdominal computed tomography 
(CT) confirmed the presence of a 57 mm 
diameter heterogeneous and irregular mass in 
the body and tail of the pancreas, encasing 
the celiac trunk. Celiac lymph nodes and 
dilatation of Wirsung’s duct were present. CT 
also revealed the presence of a demarcated, 
heterogeneously enhancing right renal mass 
52 x 40 x 54 mm in size (Fig. 1 and 2).
The patient underwent right radical 
nephrectomy and pancreatic biopsy (the 
reason for this management was the 
encasement of the celiac trunk). The operation 
was uneventful, with no postoperative 
complications. Histopathologic examination 
showed a Furhman grade II renal papillary 
carcinoma confined to the kidney, stage pT1b 
in the 2004 TNM classification (Fig. 3).
The pancreatic biopsy showed a 
well differentiated pancreatic ductal 
adenocarcinoma (Fig. 4).
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DISCUSSION                                                             
Multiple  primary  malignancies  in 
the same patient represent 1.8% to 3.9% 
of all cancers, but synchronous multiple 
primary tumors are extremely rare3, 4. Most 
synchronous primary tumors involve the 
genitourinary and the gastrointestinal tract, 
followed by both breast and genitourinary 
tract or breast and gastrointestinal tract3,5. 
Second malignancies associated with 
renal cancer include bladder tumors, non-
Hodgkin’s lymphoma, multiple myeloma, 
chronic lymphocytic leukaemia, melanoma 
and cancer of the prostate, breast, rectum and 
lung with an incidence that varies from 5% to 
27%2. A Japanese autopsy study of pancreatic 
cancer found associated malignancies in 134 
of 2394 (5.6%) autopsies, including 7 with 
renal cell cancer (0.29%)6. 
Fig. 1: Abdominal computed tomography (CT) showing
heterogeneous enhancing right renal mass.
Fig. 2: Abdominal CT:  presence of a heterogeneous and 
irregular mass lesion in the pancreatic body and tail.
Fig. 3: Microscopy of renal tumour showing tubulo-papillary 
proliferation of the renal glands (H&E x 100).
Fig. 4: Microscopy of pancreatic biopsy showing tumoral 
proliferation of the glands and fibrous desmoplasia of the 
stroma (H&E x 40).
Fig. 5: Immunohistochemical analysis showing positivity of 
pancreatic tumoral glands to anti-cytokeratin (AE1, AE2).
Immunohistochemistry showed positivity 
of the pancreatic tumoral glands to anti-
cytokeratin (AE1, AE2) (Fig. 5). The patient 
was referred to the oncology department for 
chemotherapy containing gemcitabine.
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Analysis of the Connecticut tumour re-
gistry for the period 1935-1982 revealed 
that 19% of 4176 patients with renal cell 
cancer developed a second primary mali-
gnancy (relative risk= 1.2; p<0.05)7. There 
were also 6 cases (0.14%) of pancreatic 
cancer but there was no significant asso-
ciation (relative risk=1.0)7. In a series from 
Memorial Sloan Kettering Cancer Center, 
New York comprising 763 patients who un-
derwent surgery for renal cell cancer during 
1988-1999, there was a significantly increased 
incidence of prostate, colorectal and bladder 
cancers and non-Hodgkin’s lymphoma, but 
not pancreatic ductal adenocarcinoma8. 
Toshiyuki et al9 reported a case of 
synchronous cancer of the kidney and 
pancreas. Pathologically, the renal tumor 
was a renal cell carcinoma (clear cell 
type) and the pancreatic tumor was a well 
differentiated tubular carcinoma. Alexakis 
et al2 reported two patients with a pancreatic 
ductal adenocarcinoma who also presented 
Authors                          Type of study                                                   Number of cases                                 Temporal association
Makino et al6                  Analysis of annual autopsy                                        7                                                         All 7cases  
                                                                                                                                                                             Synchronous at autopsy 
Sasaki et al10                  Single case report                                                       1                                                        Patient with PDAC
                                                                                                                                                                             RCC and polyposis coli
Kantor et al7                   4176 patients with RCC                                             6                                       PDAC metachronous to RCC
                                           Collected by the Connecticut Tumour Registry
Rabbani et al8                763 patients undergoing resection for RCC                 3                                       All 3 cases with synchronous 
                                           in a single unit                       PDAC   and 
RCC                    
Alexakis et al2               373 patients with pancreatic tumours treated               2                                              Single patient with 
                                           in a single unit                                                                                                synchronous PDAC and RCC
Olgyai et al11                 Single case report                                                         1                                 Synchronous PDAC and RCC
Toshiyuki et al9             Single case report                                                          1                                           Synchronous RCC and
                                                                                                                                                                    pancreatic tubular carcinoma
Nobili et al12                  Single case report                                                      1                         A case of pancreatic heterotopy   of    
                                                                                                                                                          duodenal wall, intraductal papillary 
                                                                                                                                                           mucinous tumor and intraepithelial 
                                                                                                                                                                neoplasm of pancreas, papillary 
                                                                                                                                                                            carcinoma of the kidney
Present case                   Single case report                                                         1                                 Synchronous PDAC and renal 
                                                                                                                                                                                   papillary carcinoma
PDAC: pancreatic ductal adenocarcinoma; RCC: renal cell carcinoma               
Table 1: Reported cases of double pancreas-kidney primary cancers.
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with renal cell carcinoma 9 months following 
nephrectomy in one case and synchronously 
in the other. 
Previous reports that  mention an asso-
ciation between pancreatic ductal adeno-
carcinoma and renal cell cancer were based 
on a small cohort of patients with pancrea-
tic cancer, and few studies provided clinical 
details2, 6-8, 10 (Table 1). In 2004, Olgyai et al11 
reported a new case of synchronous renal and 
pancreatic body cancers. Histology verified 
primary pancreatic ductal adenocarcinoma 
with synchronous primary renal clear cell 
carcinoma. Recently, Nobili et al12 reported a 
case of coexistence of two histologically dif-
ferent pancreatic neoplasms, one renal cancer 
(papillary carcinoma) and one embryogenic 
duodenal anomaly in a single patient.  
In five cases, the majority of the patients 
were males over 60 years2, 9, 11, 12. Possible 
causes for such an association include 
shared environmental risk or genetic 
factors. Cigarette smoking could be a major 
environmental risk factor for both pancreatic 
ductal adenocarcinoma and renal cell cancer, 
accounting for an approximate 2-fold 
relative risk2. 
Genetic changes linked to the development 
of synchronous tumors were investigated in 
some studies. Satake13 found a mutation in 
codon 12 of the k-ras gene in a patient with 
a synchronous tumors of the kidney and 
pancreas. Molecular investigations were not 
considered in our case because of absence 
of known familial genetic syndromes, but 
genetic analysis of synchronous tumors in 
different organs may provide information 
about the etiology of genetic changes that 
occur during carcinogenesis13. There may be a 
novel genetic link in patients with pancreatic 
ductal adenocarcinoma and renal cell cancer 
dual primaries2.
CONCLUSION                                                       
Synchronous double kidney-pancreas 
cancers are very  rare.  This association 
demands more detailed epidemiological and 
molecular investigation.                         
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